Skip to main content
. 2023 Mar 3;15(3):839. doi: 10.3390/pharmaceutics15030839

Figure 2.

Figure 2

Symptomatic progression of PD. Schematic overview of both, MS and NMS symptoms progression and variability. PD diagnosis is based in MS, but NMS usually appears years before MS could be appreciated during the prodromal stage. The severity of the symptoms results from a combination of NMS, MS, and L-DOPA-derived complications.